Published in Percept Psychophys on August 01, 1999
The role of spatial attention and other processes on the magnitude and time course of cueing effects. Cogn Process (2005) 1.13
Inhibition of return and the human frontal eye fields. Exp Brain Res (2003) 0.98
Two spatially separated attention systems in the visual field: evidence from inhibition of return. Cogn Process (2007) 0.97
Visual cognition during real social interaction. Front Hum Neurosci (2012) 0.89
Neural correlates of spatial orienting in the human superior colliculus. J Neurophysiol (2011) 0.86
Do action goals mediate social inhibition of return? Psychol Res (2011) 0.83
In search of a reliable electrophysiological marker of oculomotor inhibition of return. Psychophysiology (2014) 0.79
Inhibition of return in cue-target and target-target tasks. Exp Brain Res (2006) 0.79
Interaction between location- and frequency-based inhibition of return in human auditory system. Exp Brain Res (2006) 0.78
Involuntary cueing effects during smooth pursuit: facilitation and inhibition of return in oculocentric coordinates. Exp Brain Res (2008) 0.78
Disentangling perceptual and motor components in inhibition of return. Cogn Process (2008) 0.77
The role of attention in a joint-action effect. PLoS One (2014) 0.76
Environment- and eye-centered inhibitory cueing effects are both observed after a methodological confound is eliminated. Sci Rep (2015) 0.75
Behavioral and neural interaction between spatial inhibition of return and the Simon effect. Front Hum Neurosci (2013) 0.75
Object files across eye movements: Previous fixations affect the latencies of corrective saccades. Atten Percept Psychophys (2016) 0.75
Evidence for an attentional component in saccadic inhibition of return. Exp Brain Res (2009) 0.75
Color-based inhibition of return. Percept Psychophys (1995) 1.63
Multicenter evaluation of a new enzyme immunoassay for detection of Clostridium difficile enterotoxin A. J Clin Microbiol (1992) 1.61
Symbolic control of visual attention. Psychol Sci (2001) 1.36
Neuropsychiatric disease and Toxoplasma gondii infection. Neuroimmunomodulation (2009) 1.14
Autonomic cardiovascular control in children with obstructive sleep apnea. Clin Auton Res (1999) 1.10
The spatial distribution of inhibition of return. Psychol Sci (2001) 1.08
Comparison of media with and without 'Panmede' for the isolation of Streptobacillus moniliformis from blood cultures and observations on the inhibitory effect of sodium polyanethol sulphonate. J Med Microbiol (1985) 1.06
Practical partnerships for health and local authorities. BMJ (2000) 1.04
Smooth muscle tumor of the pleura. A case report and review of the literature. Arch Pathol Lab Med (2000) 0.98
Family-centred care for children in hospital. Cochrane Database Syst Rev (2007) 0.94
RPR 119990, a novel alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid antagonist: synthesis, pharmacological properties, and activity in an animal model of amyotrophic lateral sclerosis. J Pharmacol Exp Ther (2001) 0.94
Comparative study of voltage-sensitive sodium channel blockers in focal ischaemia and electric convulsions in rodents. Neurosci Lett (1994) 0.91
Glutamate uptake is decreased tardively in the spinal cord of FALS mice. Neuroreport (1998) 0.88
Oculocentric coding of inhibited eye movements to recently attended locations. J Exp Psychol Hum Percept Perform (2000) 0.88
Effect of pH and CO2 on in vitro susceptibility of Pseudomonas cepacia to beta-lactams. Pediatr Res (1994) 0.86
Inhibition of return in saccadic eye movements. Exp Brain Res (2000) 0.86
Riluzole prolongs survival and delays muscle strength deterioration in mice with progressive motor neuronopathy (pmn). J Neurol Sci (2000) 0.85
Rapid aimed limb movements: differential effects of practice on component submovements. J Mot Behav (1993) 0.85
Panel report: best practices for the surgical treatment of obesity. Surg Endosc (2010) 0.85
A survey of the race profiles of cyclists in the pursuit and kilo track events. Can J Sport Sci (1988) 0.84
Clonazepam induces decreased serotoninergic activity in the mouse brain. Neuropharmacology (1979) 0.83
The gap effect for eye and hand movements. Percept Psychophys (1996) 0.83
The effect of riluzole on post-traumatic spinal cord injury in the rat. Neuroreport (1996) 0.82
A quantitative study of the levels of glandular kallikrein in normal and diabetic rats. Biochem Med (1984) 0.81
Practical approaches to the treatment of severe pediatric obesity. Pediatr Clin North Am (2011) 0.81
British National Lymphoma Investigation: pilot studies of neoadjuvant chemotherapy in clinical stage Ia and IIa Hodgkin's disease. Clin Oncol (R Coll Radiol) (2001) 0.79
Pathways of serotonin-induced electrolyte transport in rat distal colon. Surgery (1991) 0.79
Acute effects of irradiation on the rat brain: protection by glutamate blockade. Eur J Pharmacol (1995) 0.79
Chemotherapy for germ cell tumours: prophylactic ciprofloxacin reduces the incidence of neutropenic fever. Clin Oncol (R Coll Radiol) (1994) 0.78
Spiro-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one derivatives are mixed AMPA and NMDA glycine-site antagonists active in vivo. Bioorg Med Chem Lett (1999) 0.78
Influence on energy kinetics and histology of different preservation solutions seen during cold ischemia in the liver. Transplant Proc (2009) 0.78
Aging and movement: variability of force pulses for saccadic eye movements. Psychol Aging (1998) 0.78
Attentional set modulates visual areas: an event-related potential study of attentional capture. Brain Res Cogn Brain Res (2001) 0.78
Hurricane Andrew and a pediatric emergency department. Ann Emerg Med (1994) 0.78
Spatially diffuse inhibition affects multiple locations: a reply to Tipper, Weaver, and Watson (1996). J Exp Psychol Hum Percept Perform (1996) 0.78
Addition of adenosine to University of Wisconsin solution: does it help? Transplant Proc (2009) 0.77
Examining location-based and object-based components of inhibition of return in static displays. Percept Psychophys (2001) 0.77
Methyl-beta-D-glucopyranoside in higher plants: accumulation and intracellular localization in Geum montanum L. leaves and in model systems studied by 13C nuclear magnetic resonance. J Exp Bot (2004) 0.77
Fixation point offsets facilitate endogenous saccades. Percept Psychophys (1998) 0.77
Delta 9-tetrahydrocannabinol-induced alterations in limbic system glucose use in the rat. Neuroreport (2001) 0.76
Miniature wireless recording and stimulation system for rodent behavioural testing. J Neural Eng (2015) 0.76
Effect of adding a papain digest of ox liver to brain heart infusion cysteine broth on the recovery of non-sporing anaerobes from simulated blood cultures. J Clin Pathol (1983) 0.75
Age differences in saccadic averaging. Psychol Aging (1999) 0.75
A time-course study of submandibular kallikrein, blood glucose and insulin of alloxan-diabetic and streptozotocin-diabetic rats. Agents Actions (1984) 0.75
Prevalence and outcome of non-alcoholic fatty liver disease in adolescents and young adults undergoing weight loss surgery. Pediatr Obes (2014) 0.75
Modulation of picrotoxin-induced forepaw myoclonus in the rat by benzodiazepines [proceedings]. Br J Pharmacol (1979) 0.75
Central properties of alpha-allophanyl-alpha-allyl-gamma-valerolactone (valofan) [proceedings]. Br J Pharmacol (1979) 0.75
Altered serotoninergic activity in mouse brain induced by clonazepam [proceedings]. Br J Pharmacol (1978) 0.75
Teacher stress and psychoneurotic symptoms. Br J Educ Psychol (1985) 0.75
Basic research funding. Science (1987) 0.75
A study of glandular kallikrein in experimental diabetes. Adv Exp Med Biol (1986) 0.75
Temporal locus of knowledge of results: a meta-analytic review. Percept Mot Skills (1995) 0.75
Histidine-tryptophan-ketoglutarate and delayed graft function after prolonged cold ischemia. Transplant Proc (2009) 0.75
Synthesis, anticonvulsant and neuroprotective activities of RP 66055, a riluzole derivative. Bioorg Med Chem (1994) 0.75
A trip to the Australian Outback. J Pediatr Nurs (1993) 0.75
Quality assurance for MRI. Part III. Adm Radiol (1988) 0.75
Is position "special" in visual attention? Evidence that top-down processes guide visual selection. Can J Exp Psychol (2001) 0.75
Back to school! Distance learning offers alternatives for administrators. Balance (1998) 0.75
Bioisosteres of 9-carboxymethyl-4-oxo-imidazo[1,2-a]indeno-[1,2-e]pyrazin-2-carboxylic acid derivatives. Progress towards selective, potent in vivo AMPA antagonists with longer durations of action. Bioorg Med Chem Lett (2001) 0.75
Hospital admissions. Cold remedies. Health Serv J (1998) 0.75
Absence makes the heart grow colder. Nurs Mirror (1984) 0.75
Synthesis of anticonvulsive AMPA antagonists: 4-oxo-10-substituted-imidaz. Bioorg Med Chem Lett (2001) 0.75
Studies of the effects of insulin, bradykinin, and captopril on blood glucose levels of alloxan-diabetic rats. Adv Exp Med Biol (1986) 0.75
The effect of age-related stereotypes on response initiation and execution. J Gen Psychol (1999) 0.75
Evidence for increased synthesis of complement C4 in the renal epithelium of rats with passive Heymann nephritis. J Am Soc Nephrol (1997) 0.75
Effect of sodium 2-n-pentadecyl-benzimidazole-5-carboxylate (M & B 35347B), an inhibitor of acetyl-CoA carboxylase, on lipogenesis and fat deposition in obese hyperglycaemic (ob/ob) and lean mice. Int J Obes (1987) 0.75
Developing the disadvantaged student at Bronx community college. NLN Publ (1971) 0.75
8-Methylureido-4,5-dihydro-4-oxo-10H-imidazo[1,2-a]indeno[1,2-e]pyrazines: highly potent in vivo AMPA antagonists. Bioorg Med Chem Lett (2000) 0.75
Are part-timers mistreated? Nurs Mirror (1984) 0.75
Stereotypes of aboriginal health. Med J Aust (1995) 0.75
Experience of discordant beta hCG results by different assays in the management of non-seminomatous germ cell tumours of the testis. Clin Oncol (R Coll Radiol) (1999) 0.75
Inhibition of return along the path of attention. Can J Exp Psychol (1996) 0.75
Effect of a hypoglycaemic agent M&B 39890A on glucagon secretion in isolated rat islets of Langerhans. Diabetologia (1987) 0.75
Indeno[1,2-b]pyrazin-2,3-diones: a new class of antagonists at the glycine site of the NMDA receptor with potent in vivo activity. J Med Chem (2000) 0.75
8-Methylureido-10-amino-10-methyl-imidazo[1,2-a]indeno[1,2-e] pyrazine-4-ones: highly in vivo potent and selective AMPA receptor antagonists. Bioorg Med Chem (2000) 0.75
4,10-Dihydro-4-oxo-4H-imidazo[1,2-a]indeno[1,2-e]pyrazin-2-carboxylic acid derivatives: highly potent and selective AMPA receptors antagonists with in vivo activity. Bioorg Med Chem Lett (2000) 0.75
Basic research funding. Science (1987) 0.75